Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine augmentation of ERP in OCD and panic disorder with agoraphobia
NL-OMON25942Not yet recruiting
- Sponsor
- Utrecht University
- Start
- Jan 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of d-cycloserine in obsessive compulsive disorder (OCD) and Agoraphobia with panic disorder (PD/A) (3 arms), sponsored by Utrecht University. Primary endpoints: Mobility Inventory and Yale-Brown Obsessive Compulsive Scale. Planned start Jan 2010; status: not yet recruiting.
02
Drugs
d-cycloserine
03
Conditions
obsessive compulsive disorder (OCD)Agoraphobia with panic disorder (PD/A)
Beyond the preview
Go deeper on NL-OMON25942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25942.